Aeginis

Product 08 of 14

A probiotic for women's urinary and vaginal health, an area with very little spaceflight research.

1Concept
2Research programme
3In development
4Ground-tested
5Analog or flight

Women's urogenital health in spaceflight is under-studied, even though women are a growing share of crews and mission lengths are increasing.

The Women's Urogenital Health Probiotic is a research programme for a probiotic that supports urinary and vaginal health. The first step is to review what is known, grade the evidence and decide which strains are justified.

Because evidence in space is so sparse, this programme also aims to define the study design that would produce reliable data in analog settings.

The problem

6-12 mo

In astronauts on 6 to 12 month ISS missions, gut, skin, nose and tongue microbes all shifted, with changes linked to skin rashes and immune alteration.

Source: published spaceflight studies and NASA planning figures; refers to work by other groups.

The science

Why this approach.

Urinary and vaginal health depend on a balanced microbial community, often dominated by Lactobacillus species in healthy women. Disruptions can lead to infections that are painful, can spread and are hard to manage far from medical care. Very little research addresses these conditions in spaceflight.

The programme starts with an evidence review and a strain safety screen, then defines what a well-designed study would look like in an analog population. Because spaceflight data barely exist, the goal is as much to define a trustworthy study as to produce a product.

In use

Across the length of a mission.

How this product is intended to fit into a crew's routine, from loading to return.

Design

Four decisions that shape it.

Evidence review

Published urogenital probiotic literature graded by study type and setting.

Strain selection

Candidate strains with a record of safety and relevant function.

Stable format

Delivered in a shelf-stable form compatible with long storage.

Study design

A defined endpoint set before any analog trial.

Risks

What could go wrong, and what we do about it.

RiskHow we address it
Little existing evidenceEvidence grading and an explicit study design before claims.
Ethics and privacyAppropriate oversight and data protection in any study.
Strain suitabilityStrain-level screening and characterisation.

Test plan

Ground, analog, orbit.

A staged programme: ground first, then analog crews, then flight.

Step 1

Ground testing

Strain characterisation and storage stability.

Step 2

Isolated-crew studies

Analog studies with appropriate ethics and oversight.

Step 3

Flight testing

Later stage, subject to ground results.

Step 4

Partnerships

Women's health researchers and space-medicine groups.

Questions

FAQ.

Why is there so little research?

Spaceflight health research has historically focused on a small number of crew, and women's urogenital health has received little attention.

Is it a treatment?

No. It is a research programme and not intended to diagnose, treat, cure or prevent any disease.

All products on this site are under research and development. They are not approved or cleared by any regulator and are not available for sale. Nothing here is medical advice, and no product is intended to diagnose, treat, cure or prevent any disease. Descriptions of research refer to published studies by other groups and do not claim that our products have been proven in space. Women's Urogenital Health Probiotic is a product under research and development and is not available for sale.

Let's build the next shield together.

Space agencies, station builders, research institutes and sustainable-construction partners: we would like to hear from you.